Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction products of (E)-5-((4-amino-5-methoxy-2-methylphenyl)diazenyl)-3-((phenylsulfonyl)oxy)naphthalene-2,7-disulfonic acid condensate with cyanurchloride, then condensate with (E)-7-amino-4-hydroxy-3-((2-methoxy-5-sulfophenyl)diazenyl)naphthalene-2-sulfonic acid, finally condensate with aniline, sodium salts
EC number: 946-990-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Test substance is one component of the target (UVCB) substance; it is one of the major components, ranging between 10 - 60 % w/w. Other components show slight differences in terms of position / type of functional groups.
- Adequacy of study:
- key study
- Study period:
- From January 12 to 27, 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Source study has reliability 2, as only 4 strains of Salmonella typhimurium were included, with respect to the 5 strains required by the currently accepted version of the guideline. Details on the read across are available in section 13.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1983
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 1992
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Similar Substance 01
- IUPAC Name:
- Similar Substance 01
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver microsomal activation
- Test concentrations with justification for top dose:
- 33.3, 100.0, 333.3, 1000.0, 2500.0 and 5000.0 µg/plate as a.i., based on results of a pre-experiment on toxicity.
- Vehicle / solvent:
- - Vehicle: water
The solvent was chosen because of the solubility properties.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 4-nitro-o-phenylene-diamine
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- THE TEST SYSTEM
Characterisation of the Salmonella typhimurium strains
The strains are derived from S. typhimurium strain LT2 and due to a mutation in the histidine locus are histidine dependent. Additionally, due to the "deep rough" (rfa-minus) mutation, they possess a faulty lipopolysaccharide envelope which enables substances to penetrate the cell wall more easily. A further mutation causes a reduction in the activity of an excision repair system. The latter alteration includes mutational processes in the nitrate reductase and biotin genes produced in a UV-sensitive area of the gene named "uvrB-minus". In the strains TA 98 and TA 100 the R-factor plasmid pKM 101 carries the ampicillin resistance marker.
In summary, the mutations of the TA strains used in this study can be described as:
- frame shift mutations
TA 1537: his C 3076; rfa-; uvrB-;
TA 98: his D 3052; rfa-; uvrB-; R-factor
- base-pair substitutions
TA 1535: his G 46; rfa-; uvrB-;
TA 100: his G 46; rfa-; uvrB-;R-factor
Storage
The strain cultures were stored as stock cultures in ampoules with nutrient broth + 5 % DMSO in liquid nitrogen.
Precultures
From the thawed ampoules of the strains 0.5 ml suspension was transferred to 250 ml Erlenmeyer flasks containing 20 ml nutrient medium. A solution of 20 ul ampicillin was added to the strains TA 98 and TA 100. This nutrient medium contains per litre:
8 g Merck Nutrient Broth
5 g NaCl
The bacterial culture was incubated in a shaking water bath for 10 hours at 37 °C.
Selective Agar
2.0 % Vogel-Bonner-Glucose-Minimal-Agar was used as selective agar. Each petri dish was filled with 20 ml of this nutrient medium.
Sterilisations were performed at 121 °C in an autoclave.
Overlay Agar
The overlay agar contains per litre:
6.0 g Merck Agar Agar
6.0 g NaCl
10.5 mg L-histidine × HCl × H2O
12.2 mg biotin
Sterilisations were performed at 121 °C in an autoclave.
MAMMALIAN MICROSOMAL FRACTION S9 MIX
The bacteria used in these assays do not possess the enzyme systems which, in mammals, are known to convert promutagens into active DNA damaging metabolites. In order to overcome this major drawback an exogenous metabolic system is added in form of mammalian microsome enzyme activation mixture.
S9 (Preparation by C C R)
The S9 liver microsomal fraction was obtained from the livers of 8 - 12 weeks old male Wistar rats, strain WU, which received a single i.p. injection of 500 mg/kg b.w. Aroclor 1254 in olive oil 5 days previously.
After cervical dislocation the livers of the animals were removed, washed in 150 mM KCl and homogenised. The homogenate was diluted 1+3 in KCl and centrifuged cold at 9,000 g for 10 minutes. A stock of the supernatant containing the microsomes was frozen in ampoules of 2, 3 or 5 ml and stored at -80 °C. Small numbers of the ampoules are kept at -20 °C for only one week before use.
The protein concentration in the S9 preparation was 37.4 mg/ml.
S9 mix
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 co-factor solution. The amount of S9 supernatant was 15 % v/v. The composition of the co-factor solution was concentrated to yield the following concentrations in the S9 mix:
8 mM MgCl2
33 mM KCl
5 mM glucose-6-phosphate
5 mM NADP
in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.
During the experiment the S9 mix was stored in an ice bath.
PRE-EXPERIMENT FOR TOXICITY
To evaluate the toxicity of the test article a pre-experiment was performed with strains TA 98 and TA 100. 8 concentrations were tested for toxicity and mutation induction with each 3 plates. The experimental conditions in this pre-experiment were the same as described below for the experiment I (plate incorporation test).
Toxicity of the test article can be evidenced by a reduction in the number of spontaneous revertants, a clearing of the bacterial background lawn, or by degree of survival of treated cultures.
DOSE SELECTION
According to the results of this pre-experiment the concentrations applied in the main experiments were chosen. The concentration range covered 2 logarithmic decades.
The maximum concentration was 5000.0 µg/plate. The concentration range included two logarithmic decades. In this study 6 adequately spaced concentrations were tested. Two independent experiments were performed.
As the results of the pre-experiment were in accordance with the criteria for evaluation of results, these data are reported as a part of the main experiment I.
According to the dose selection criteria, test substance was tested at the following concentrations:
33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 µg/plate as active ingredient.
EXPERIMENTAL PERFORMANCE
For each strain and dose level, including the controls 3 plates were used as a minimum. The following materials were mixed in a test tube and poured onto the selective agar plates:
100 µl test solution at each dose level, solvent control, negative control, or reference mutagen solution (positive control),
500 µl S9 mix (for test with metabolic activation) or S9 mix substitution-buffer (for test without metabolic activation),
100 µl bacteria suspension,
2000 µl overlay agar
In the pre-incubation assay 100 µl test solution, 500 µl S9 mix / S9 mix substitution buffer and 100 µl bacterial suspension were mixed in a test tube and incubated at 37 °C for 60 minutes. After pre-incubation 2.0 ml overlay agar (45°) was added to each tube.
The mixture was poured on minimal agar plates.
After solidification the plates were incubated upside down for at least 48 hours at 37 °C in the dark. - Evaluation criteria:
- EVALUATION OF RESULTS
The generally accepted conditions for the evaluation of the results are:
- corresponding background growth on both negative controls and test plates
- normal range of spontaneous reversion rates.
Range of spontaneous reversion frequencies (values referred to negative control without metabolic activation and represent historical control range in 1993)
1535 1537 98 100
10 - 29 5 - 28 15 - 57 77 - 189
Due to international guidelines a statistical evaluation of the results is recommended. However, no evaluated statistical procedure can be recommended for analysis of data from the bacterial assays at this time.
A test article is considered positive if either a dose related and reproducible increase in the number of revertants or a significant and reproducible increase for at least one test concentration is induced.
A test article producing neither a dose related and reproducible increase in the number of revertants nor a significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
A significant response is described as follows:
A test article is considered mutagenic if in strain TA 100 the number of reversions is at least twice as high and in strains TA 1535, TA 1537 and TA 98 at least three times higher as compared to the spontaneous reversion rate.
Also, a dose-dependent and reproducible increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test article regardless whether the highest dose induced the above described enhancement factors or not.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- without S9 mix: 100 µg/plate (exp.I); up to 1000 µg/plate (exp. II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- without S9 mix: at 100 µg/plate (exp. I)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Test substance was assessed for its potential to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100.
The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration and the controls were tested in triplicate.
Slight toxic effects occurred in strains TA 1535 and TA 1537 at 100 µg/plate without S9 mix in experiment I. In experiment II, toxic effects occurred in strain TA 1535 up to 1000 µg/plate without S9 mix.
The plates incubated with test substance showed normal background growth up to 5000.0 µg/plate with and without S9 mix in all strains used.
Slight increases in revertant colony numbers were observed in strain TA 1537 at 5000.0 µg/plate without S9 mix and at 2500.0 µg/plate with S9 mix as well as in strain TA 98 at 5000.0 µg/plate with S9 mix in experiment II. These effects are considered being biologically irrelevant since they are due to the relatively low level of the corresponding solvent control (strain TA 1537) and could not be reproduced in the independent experiment (strain TA 1537 and TA 98).
Appropriate reference mutagens were used as positive controls. They showed a distinct increase in induced revertant colonies.
In conclusion, test substance did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Any other information on results incl. tables
Without S9 mix
conc. µg/plate | TA 1535 | TA 1537 | TA 98 | TA 100 | ||||
I | II | I | II | I | II | I | II | |
negative control | 14 | 11 | 8 | 7 | 32 | 18 | 94 | 112 |
solvent control | 17 | 12 | 12 | 8 | 32 | 16 | 91 | 112 |
33.3 | 14 | 5 | 10 | 10 | 28 | 17 | 97 | 102 |
100.0 | 8 | 8 | 6 | 10 | 29 | 15 | 106 | 115 |
333.3 | 17 | 6 | 11 | 8 | 34 | 14 | 103 | 117 |
1000.0 | 16 | 10 | 9 | 9 | 26 | 18 | 94 | 108 |
2500.0 | 13 | 9 | 13 | 11 | 20 | 16 | 107 | 112 |
5000.0 | 12 | 13 | 15 | 16 | 26 | 13 | 118 | 112 |
positive control sodium azide 10 µg/plate |
741 | 350 | 710 | 337 | ||||
4-nitro-o-phenylene-diamine 10 µg/plate |
38 | 35 | 186 | 376 |
With S9 mix
conc. µg/plate | TA 1535 | TA 1537 | TA 98 | TA 100 | ||||
I | II | I | II | I | II | I | II | |
negative control | 12 | 10 | 23 | 10 | 45 | 21 | 133 | 141 |
solvent control | 15 | 14 | 21 | 8 | 41 | 19 | 134 | 136 |
33.3 | 15 | 14 | 22 | 9 | 36 | 20 | 120 | 133 |
100.0 | 16 | 13 | 22 | 9 | 35 | 24 | 140 | 153 |
333.3 | 12 | 11 | 16 | 10 | 39 | 23 | 118 | 149 |
1000.0 | 14 | 13 | 27 | 9 | 35 | 26 | 137 | 162 |
2500.0 | 13 | 11 | 29 | 18 | 38 | 31 | 126 | 149 |
5000.0 | 12 | 11 | 30 | 15 | 46 | 55 | 128 | 158 |
positive control 2-amino-anthracene (2.5 µg/plate) |
62 | 80 | 86 | 12 | 177 | 85 | 483 | 299 |
Applicant's summary and conclusion
- Conclusions:
- Under experimental conditions, test substance did not induce gene mutations by base pair changes or frameshifts in the genome of TA98, TA 100, TA1535, TA 1537 strains.
- Executive summary:
Method
The potential of test substance to induce gene mutations was assessed in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100.
The assay was performed in two independent experiments, both with and without liver microsomal activation. Solvent controls, untreated (negative) controls and positive controls were run. Each concentration, including controls, was tested in triplicate. Test substance was dissolved in water and was tested at concentrations of 33.3; 100.0; 333.3; 1000.0; 2500.0; and 5000.0 µg/plate as active ingredient.
Results
Slight toxic effects occurred in strains TA 1535 and TA 1537 at 100 µg/plate without S9 mix in experiment I. In experiment II, toxic effects occurred in strain TA 1535 up to 1000 µg/plate without S9 mix.
The plates incubated with test substance showed normal background growth up to 5000.0 µg/plate with and without S9 mix in all strains used.
Slight increases in revertant colony numbers were observed in strain TA 1537 at 5000.0 µg/plate without S9 mix and at 2500.0 µg/plate with S9 mix as well as in strain TA 98 at 5000.0 µg/plate with S9 mix in experiment II. These effects were considered as biologically irrelevant, due to the relatively low level of the corresponding solvent control (strain TA 1537) and could not be reproduced in the independent experiment (strain TA 1537 and TA 98).
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Overall, test substance was considered as non-mutagenic in the Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.